UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lowered by Personal CFO Solutions LLC

Personal CFO Solutions LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,414 shares of the healthcare conglomerate’s stock after selling 25 shares during the quarter. Personal CFO Solutions LLC’s holdings in UnitedHealth Group were worth $2,324,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the stock. Wellington Management Group LLP increased its stake in shares of UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Capital Research Global Investors increased its stake in shares of UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after purchasing an additional 324,733 shares during the last quarter. Capital International Investors grew its stake in UnitedHealth Group by 4.8% in the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after buying an additional 542,424 shares during the last quarter. Norges Bank acquired a new position in UnitedHealth Group in the 4th quarter valued at $5,802,231,000. Finally, Northern Trust Corp grew its stake in UnitedHealth Group by 3.6% in the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after buying an additional 341,749 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Deutsche Bank Aktiengesellschaft increased their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Finally, Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $578.75.

UnitedHealth Group Price Performance

UNH traded down $11.23 during midday trading on Friday, hitting $490.69. The company had a trading volume of 3,416,349 shares, compared to its average volume of 3,176,139. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $451.63 billion, a PE ratio of 29.99, a P/E/G ratio of 1.46 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The firm’s 50-day simple moving average is $490.35 and its 200-day simple moving average is $507.82.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.26 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Friday, June 14th. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.